NCT03890900View on ClinicalTrials.gov

T2DXcel Mobile Application

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

T2DXcel mobile application

T2DXcel is a mobile application (patient-facing) that delivers guideline-based diabetes education.

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT03890900 - T2DXcel Mobile Application | Biotech Hunter | Biotech Hunter